Portal de Periódicos da CAPES

Idiopathic pulmonary fibrosis: a ruthless killer

2019; Mark Allen Group; Volume: 26; Issue: 3 Linguagem: Inglês

10.12968/ijtr.2019.0042

1759-779X

Massimiliano Polastri, Ilaria Bassi, Aldo Guerrieri,

Occupational exposure and asthma

International Journal of Therapy and RehabilitationVol. 26, No. 3 EditorialIdiopathic pulmonary fibrosis: a ruthless killerMassimiliano Polastri, Ilaria Bassi, Aldo GuerrieriMassimiliano PolastriCorrespondence to: Massimiliano Polastri Email:E-mail Address: [email protected]Physiotherapist, Medical Department of Continuity of Care and Disability, Physical Medicine and Rehabilitation, St Orsola University Hospital, Bologna, Italy, Ilaria BassiDoctor, Department of Specialistic-Diagnostic and Experimental Medicine (DIMES), University of Bologna, Bologna, Italy, Aldo GuerrieriPulmonologist, Department of Cardiac-Thoracic-Vascular Diseases, Unit of Pulmonology, St Orsola University Hospital, Bologna, ItalyMassimiliano Polastri; Ilaria Bassi; Aldo GuerrieriPublished Online:30 Mar 2019https://doi.org/10.12968/ijtr.2019.0042AboutSectionsView articleView Full TextPDF/EPUB ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareShare onFacebookTwitterLinked InEmail View article References Agabiti N, Porretta MA, Bauleo L, et al.. Idiopathic pulmonary fibrosis (IPF) incidence and prevalence in Italy. Sarcoidosis Vasc Diffuse Lung Dis. 2014;31(3):191–197 Google ScholarBurnett K, Glaspole I, Holland AE. Understanding the patient's experience of care in idiopathic pulmonary fibrosis. Respirology. 2018;24(3):270–277. https://doi.org/10.1111/resp.13414 Crossref, Google ScholarBritish Lung Foundation. Pulmonary fibrosis services in the UK. 2016. https://tinyurl.com/y6hezzea (accessed 21 March 2019) Google ScholarDowman LM, McDonald CF, Hill CJ et al.. The evidence of benefits of exercise training in interstitial lung disease: a randomised controlled trial. Thorax. 2017;72(7):610–619. https://doi.org/10.1136/thoraxjnl-2016-208638 Crossref, Google ScholarJastrzebski D, Gumola A, Gawlik R, Kozielski J. Dyspnea and quality of life in patients with pulmonary fibrosis after six weeks of respiratory rehabilitation. J Physiol Pharmacol. 2006;57(Suppl 4):139–148 Google ScholarJones PW, Quirk FH, Baveystock CM. The St George's Respiratory Questionnaire. Respir Med 1991;85(Suppl B):25–31 Crossref, Google ScholarKarakatsani A, Papakosta D, Rapti A et al.. Epidemiology of interstitial lung diseases in Greece. Respir Med. 2009;103(8):1122–1129. https://doi.org/10.1016/j.rmed.2009.03.001 Crossref, Google ScholarKishaba T. New era of idiopathic pulmonary fibrosis. Respir Investig. 2018;56(6):427–429. https://doi.org/10.1016/j.resinv.2018.08.008 Crossref, Google ScholarKropski JA, Blackwell TS. Progress in understanding and treating idiopathic pulmonary fibrosis. Annu Rev Med. 2019;70:211–224. https://doi.org/10.1146/annurev-med-041317-102715 Crossref, Google ScholarOsservatorio Malattie Rare. IPF, Guida ai centri italiani per la Fibrosi Polmonare Idiopatica. 2017. Available at https://tinyurl.com/y3bhscxq (accessed 21 March 2019). Google ScholarRaghu G. Idiopathic pulmonary fibrosis. A rational clinical approach. Chest. 1987;92(1):148–154 Crossref, Google ScholarSakamoto K, Kaminski M. Genomics of lung fibrosis. In: Selman MPardo A. Contemporary approaches to idiopathic pulmonary fibrosis. London: Future Medicine Ltd; 2015: 8–10 Crossref, Google ScholarSalvatore M, Smith ML. Cross sectional imaging of pulmonary fibrosis translating pathology into radiology. Clin Imaging. 2018;51:332–336. https://doi.org/10.1016/j.clinimag.2018.06.013 Crossref, Google ScholarSpagnolo P, Tzouvelekis A, Bonella F. The management of patients with idiopathic pulmonary fibrosis. Front Med (Lausanne). 2018;5:148. https://doi.org/10.3389/fmed.2018.00148 Crossref, Google ScholarSpek CA, Duitman J. Is idiopathic pulmonary fibrosis a cancer-like disease? Transcriptome analysis to fuel the debate. ERJ Open Res. 2019;5(1):0157-2018. https://doi.org/10.1183/23120541.00157-2018 Crossref, Google ScholarSpruit MA, Singh SJ, Garvey C et al.. An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med. 2013;188(8):e13–64. https://doi.org/10.1164/rccm.201309-1634ST Crossref, Google ScholarStrongman H, Kausar I, Maher TM. Incidence, prevalence and survival of patients with idiopathic pulmonary fibrosis in the UK. Adv Ther. 2018;35(5):724–736. https://doi.org/10.1007/s12325-018-0693-1 Crossref, Google ScholarVainshelboim B, Oliveira J, Yehoshua L et al.. Exercise training-based pulmonary rehabilitation program is clinically beneficial for idiopathic pulmonary fibrosis. Respiration. 2014;88(5):378–388. https://doi.org/10.1159/000367899 Crossref, Google Scholarvon Plessen C, Grinde O, Gulsvik A. Incidence and prevalence of cryptogenic fibrosing alveolitis in a Norwegian community. Respir Med. 2003;97(4):428–435. https://doi.org/10.1053/rmed.2002.1466 Crossref, Google ScholarWare JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30(6):473–483 Crossref, Google ScholarXaubet A, Ancochea J, Morell F et al.. Report of the incidence of interstitial lung diseases in Spain. Sarcoidosis Vasc Diffuse Lung Dis. 2004;21(1):64–70 Google Scholar FiguresReferencesRelatedDetailsCited byPalliative physiotherapy in end-stage respiratory diseasesMassimiliano Polastri, Anna Maria Cuomo30 August 2022 | International Journal of Therapy and Rehabilitation, Vol. 29, No. 8Combining thalassotherapy and exercise for people with respiratory diseasesMassimiliano Polastri, Gian Maria Paganelli, Irene Prediletto30 June 2022 | International Journal of Therapy and Rehabilitation, Vol. 29, No. 6 2 March 2019Volume 26Issue 3ISSN (online): 1759-779X Metrics History Published online 30 March 2019 Published in print 2 March 2019 Information© MA Healthcare LimitedPDF download